Cystic fibrosis: Selecting the prenatal screening strategy of choice

Prenatal Diagnosis

Volumn 23, Issue 6, 2003, Pages 474-483

  Wald, N J ^a   Morris, J K ^a   Rodeck, C H ^b   Haddow, J E ^c   Palomaki, G E ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

Couple screening; Cystic fibrosis; Prenatal screening

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

AUTOSOMAL RECESSIVE DISORDER; BLOOD SAMPLING; CHORION VILLUS SAMPLING; CYSTIC FIBROSIS; DNA DETERMINATION; GENETIC COUNSELING; HIGH RISK PREGNANCY; HUMAN; HUMAN CELL; LIFE EXPECTANCY; MEDICAL DECISION MAKING; PILOT STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW;

ADULT; CYSTIC FIBROSIS; FAMILY CHARACTERISTICS; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; MALE; PRECONCEPTION CARE; PREGNANCY;

EID: 0038123025     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.618     Document Type: Review

References (44)

1. Abeliovich D, Lavon IP, Lerer I, et al. 1992. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1: 29 in the Jewish Ashkenazi population. Am J Hum Genet 32: 951-956.
2. American College of Obstetricians and Gynecologists, American College of Medical Genetics. 2001. Preconception and Prenatal Carrier Screening for Cystic Fibrosis: Clinical and Laboratory Guidelines, Washington DC, ACOG.
3. Bekker H, Modell M, Denniss G, et al. 1993. Uptake of cystic fibrosis testing in primary care: supply push or demand pull. BMJ 306: 1584-1586.
4. Bowler IM, Estlin EL, Littlewood JM. 1993. Cystic fibrosis in Asians. Arch Dis Child 68: 120-122.
5. British Paediatric Association Working Party on Cystic Fibrosis. 1988. Cystic fibrosis in the United Kingdom 1977-85; an improving picture. BMJ 197: 1599-1602.
6. Brock DJH. 1996. Prenatal screening for cystic fibrosis: 5 years' experience reviewed. Lancet 347: 148-150.
7. Brock DJH. 2000. Cystic fibrosis. In Antenatal and Neonatal Screening (2nd edn), Wald NJ, Leck I (eds). Oxford University Press: Oxford.
8. Cuckle HS, Richardson GA, Sheldon TA, Quirke P. 1995. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311: 1460-1464.
9. Curtis A, Richardson RJ, Boohene J, Jackson A, Nelson R, Bhattacharya SS. 1993. Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of homozygous S549N mutation in an inbred Pakistani family. J Med Genet 30: 164-166.
10. Cystic Fibrosis Foundation. 2000. Patient Registry 1994 Annual Report, Bethesda, MD.
11. Cystic Fibrosis Genetic Analysis Consortium. 1994. Population variation of common cystic fibrosis mutations. Hum Mutat 4: 167-177.
12. Doherty RA, Palomaki GE, Kloza EM, Erickson JL, Haddow JE. 1996. Couple based prenatal screening for cystic fibrosis in primary care settings. Prenat Diagn 16: 397-404.
13. Elbourne JS, Shale DJ, Britton JR. 1991. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 46: 881-885.
14. Estivill X, Bancells C, Ramos C, The Biomed CF Mutation Analysis Consortium. 1997. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. Hum Mutat 10: 135-154.
15. Farrell PM, Kosorok MR, Laxova A, et al. 1997. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 337: 963-969.
16. Farrell PM, Kosorok MR, Rock MJ, et al. 2001. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves longterm growth. Pediatrics 107: 113-116.
17. Georgi S, Tandoi C, Ciminelli BM, Modiano G. 1997. A correction of the estimates of the least common cystic fibrosis (CF) mutations published by the Cystic Fibrosis Genetic Analysis Consortium in 1994. Gene Geograph 11: 57-59.
18. Haddow JE. 1997. Why the term "carrier screening" should be abandoned. J Med Screen 4: 176.
19. Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR. 1998. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 132: 255-259.
20. Kerem E, Kalman YM, Yahav Y, et al. 1995. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet 96: 193-197.
21. Kerem B, Kerem T. 1996. The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet 4: 65-73.
22. Livingstone J, Axton RA, Gilfillan A, et al. 1994. Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ 308: 1459-1462.
23. Marteau TM, Michie S, Miedzybrodzka ZH, Allanson A. 1999. Incorrect recall of residual risk three years after carrier screening for cystic fibrosis: a comparison of two-step and couple screening. Am J Obstet Gynecol 181: 165-169.
24. Mennie ME, Axworthy D, Liston WA, Brock DJ. 1997. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women? Prenat Diagn 17: 853-860.
25. Merelle ME, Nagelkerke AF, Lees CM, Dezateux C. 2001. Newborn screening for cystic fibrosis. Cochrane Review. In: The Cochrane Library, Issue 1, 2003. Oxford. Update Software.
26. Miedzybrodzka ZH, Hall MH, Mollison J, et al. 1995. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ 310: 353-357.
27. Murray J, Cuckle H, Taylor G, Littlewood J, Hewison J. 1999. Screening for cystic fibrosis. Health Technol Assess 3: 8.
28. Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. 2002. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians. Genet Med 4: 90-94.
29. Payne Y, Williams M, Cheadle J, et al. 1997. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. Clin Genet 51: 153-163.
30. Philips OP, Bishop C, Woods D, Elias S. 1995. Cystic fibrosis mutations among African Americans in the southeastern United States. J Nat Med Assoc 87: 433-435.
31. Powers CA, Potter EM, Wessle HU, Lloyd-Still JD. 1996. Cystic fibrosis in Asian Indians. Arch Pediatr Adolesc Med 150: 554-555.
32. Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. 1992. A cost description of an adult cystic fibrosis unit and cost analysis of different categories of patients. Thorax 47: 684-689.
33. Sheldon TA, Simpson J. 1991. Appraisal of a new scheme for prenatal screening for Down's syndrome. BMJ 302: 1133-1136.
34. Spencer A, Venkataraman M, Higgins S, Stevenson K, Weller PH. 1994. Cystic fibrosis in children from ethnic minorities in the West Midlands. Respir Med 88: 671-675.
35. Strom CM, Huang D, Buller A, et al. 2002. Cystic fibrosis screening using the college panel: platform comparison and lessons learned from the first 20,000 samples. Genet Med 4: 289-296.
36. Tambor ES, Bernhardt BA, Chase G, et al. 1994. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet 55: 626-637.
37. Wald NJ. 1991. Couple screening for cystic fibrosis. Lancet 338: 1218-1219.
38. Wald NJ. 1995. Biochemical detection of neural tube defects and Down's syndrome. In Turnbull's Obstetrics (2nd edn), Chamberlain G (ed.). Churchill Livingstone: Edinburgh; 195-209.
39. Wald NJ, Brock DJ, Haddow JE, Doherty RA. 1995b. Antenatal screening for cystic fibrosis. BMJ 310: 1199.
40. Wald NJ, Densen JW, George L, et al. 1996. Prenatal screening for Down's syndrome using Inhibin-A as a serum marker. Prenat Diagn 16: 143-153.
41. Wald NJ, George LM, Wald NM. 1993. Couple screening for cystic fibrosis. Lancet 342: 1307-1308.
42. Wald NJ, George L, Wald N, MacKenzie IZ. 1995a. Further observations in connection with couple screening for cystic fibrosis. Prenat Diagn 15: 589-590.
43. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
44. Watson EK, Mayall E, Chapple J, et al. 1991. Screening for carriers of cystic fibrosis through primary health care services. BMJ 303: 504-507.